查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976590

内分泌检测市场：按类型、产品类型、检体类型、技术、疾病类型和最终用户划分－2026-2032年全球预测

Endocrine Testing Market by Type, Product Type, Sample Type, Technology, Disease Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内分泌检测市场价值将达到 108.8 亿美元，到 2026 年将成长至 117.8 亿美元，到 2032 年将达到 194.2 亿美元，复合年增长率为 8.61%。

主要市场统计数据
基准年 2025 108.8亿美元
预计年份：2026年 117.8亿美元
预测年份 2032 194.2亿美元
复合年增长率 (%) 8.61%

本报告重点阐述了关键驱动因素、新兴技术和市场基础，将荷尔蒙检测置于现代医疗策略的前沿。

内分泌检测已成为现代医学的重要支柱，为多种荷尔蒙失调的诊断和治疗提供支持。检测灵敏度的提高，以及对内分泌病理学更深入的理解，使得这些检测从常规临床工具跃升为促进以病人为中心的医疗服务的策略性手段。糖尿病、甲状腺功能障碍和肾上腺疾病等疾病的日益普遍，使得准确可靠的诊断变得特别迫切。同时，个人化医疗的发展也要求检测实验室和检测研发人员提供快速、多样化且微创的解决方案。

本检验了技术创新、监管改革和以病人为中心的照护模式为内分泌诊断带来的变革性变化。

近年来，在尖端技术创新和不断变化的监管要求的推动下，内分泌诊断领域经历了翻天覆地的变化。串联式质谱质谱和高通量免疫检测在检查室工作流程的应用，显着提升了诊断的准确性和处理能力。同时，全球监管机构不断实施更严格的检验要求和品质标准，迫使生产商在合规和文件编制流程方面投入巨资。

在经济环境波动的情况下，评估美国关税到 2025 年对内分泌检测供应链和市场营运的累积影响。

随着2025年进口试剂、设备和配件关税结构的调整，内分泌检测供应链的韧性备受关注。检测实验室和设备供应商面临不断上涨的投入成本，被迫全面检视其筹资策略。许多机构正在加速供应商网路多元化，并建立区域分销中心，以降低成本上涨和运输延误的风险。

揭示了影响市场的关键细分见解，包括测试类型、产品类型、检体介质、技术、疾病分类和最终用户。

对市场区隔的详细分析揭示了内分泌诊断生态系统中各种检测类型和应用领域的复杂结构。皮质醇测定仍然是评估肾上腺功能的重要工具，而硫酸去氢表雄酮（DHEA-S）检测在评估肾上腺雄激素生成的重要性日益凸显。雌二醇测定是生殖健康监测的基础，人类绒毛膜促性腺激素分泌（hCG）检测则有助于不孕症的诊治和怀孕后续观察。胰岛素测定对于血糖控制至关重要，性荷尔蒙谱检测可提供全面的内分泌分析，而甲状腺刺激素）分析则是甲状腺疾病诊治的基础。

本报告重点分析了美洲、欧洲、中东和非洲以及亚太地区的关键区域趋势，揭示了清晰的需求模式、采用率和成长要素。

内分泌检测领域的区域趋势呈现出显着差异，反映了不同服务提供者在监管环境、报销机制和患者群体特征方面的差异。在美洲，完善的报销机制和成熟的检测网路促进了先进检测平台的快速部署。学术机构与私人企业之间的合作研究倡议进一步强化了创新管道，推动了新型诊断方法的试点应用。

主要产业参与者概况：策略联盟、创新组合和不断演变的竞争优势塑造了全球内分泌检测市场

内分泌诊断领域的主要企业正透过策略联盟、产品组合精简和技术创新来加强自身差异化优势。现有试剂和仪器製造商正与生物製药公司合作，共同开发伴随诊断产品；同时，诊断专家也在整合数位健康平台，以简化数据管理和远端监测流程。

为内分泌诊断领域的产业领导者提供关于技术整合、策略伙伴关係和新兴市场拓展的实用建议。

我们鼓励业界领导者采用灵活的平台，实现免疫检测和质谱联用，加速下一代技术的整合。这种整合将简化工作流程，降低整体拥有成本。同时，它也将促进与契约製造和区域分销商的策略伙伴关係，降低供应链风险，并助力企业快速进入高成长市场。

详细介绍采用综合调查方法，结合一手访谈、二手分析和资料三角验证，确保对市场有深入的洞察。

本分析采用严谨的混合方法研究设计，确保全面覆盖和分析准确性。主要研究工作包括透过对高阶主管、临床实验室经理、关键意见领袖 (KOL) 和采购专家进行结构化访谈来收集见解。这些访谈揭示了整个价值链中目前面临的营运挑战、未满足的需求和策略重点。

总结观点，重点阐述策略需求、未来前景和引领全球内分泌检测发展的综合创新。

内分泌检测市场正处于转折点，技术的快速进步、法规环境的不断变化以及患者期望的演变共同作用，重新定义了诊断模式。细分市场分析突显了临床检查室、研究机构和照护现场提供者的不同需求，而区域洞察则强调了适应性打入市场策略的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内分泌检测市场：依类型划分

  • 皮质醇测试
  • 脱氢表雄酮硫酸酯（DHEAS）检测
  • 雌二醇 (E2) 检测
  • 人类绒毛膜促性腺激素分泌(hCG) 荷尔蒙检测
  • 胰岛素测试
  • 性荷尔蒙检测
  • 甲状腺刺激素（TSH）检测

第九章 内分泌检测市场：依产品类型划分

  • 装置
    • 层析法系统
    • 免疫检测分析仪
    • 质谱系统
  • 试剂和试剂盒
    • 校正试剂
    • 管理材料
    • 诊断试剂盒
  • 软体和服务
    • 资讯解决方案
    • 维护服务

第十章 依检体类型分類的内分泌检测市场

  • 血
  • 唾液
  • 尿

第十一章 内分泌检测市场：依技术划分

  • 临床化学
  • 免疫检测
  • 单株和多株抗体技术
  • 感测器技术
  • 串联式质谱质谱法

第十二章 内分泌检测市场：依疾病类型划分

  • 肾上腺疾病
    • 爱迪生氏症
    • 库欣氏症候群
  • 糖尿病
  • 性腺疾病
    • 性腺功能减退
    • 卵巢症候群
  • 甲状腺功能障碍
    • 甲状腺功能亢进
    • 甲状腺机能低下症

第十三章 内分泌检测市场：依最终用户划分

  • 学术机构
  • 诊断检查室
  • 医院和诊所
  • 研究机构

第十四章 内分泌检测市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 内分泌检测市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 内分泌检测市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国内分泌检测市场

第十八章：中国内分泌检测市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd
  • bioMerieux SA
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin SpA
  • Eagle Biosciences
  • EKF Diagnostics Holdings Plc
  • Eli Science Inc.
  • Eurofins Analytical Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • MP Biomedicals, LLC
  • Ortho-Clinical Diagnostics, Inc.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
Product Code: MRR-69324464D0E6

The Endocrine Testing Market was valued at USD 10.88 billion in 2025 and is projected to grow to USD 11.78 billion in 2026, with a CAGR of 8.61%, reaching USD 19.42 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.88 billion
Estimated Year [2026] USD 11.78 billion
Forecast Year [2032] USD 19.42 billion
CAGR (%) 8.61%

Positioning Hormone Testing at the Forefront of Modern Healthcare Strategies by Highlighting Key Drivers, Emerging Innovations, and Market Foundations

The field of endocrine testing has emerged as a critical pillar of modern healthcare, underpinning the diagnosis and management of a wide array of hormonal disorders. Advances in assay sensitivity, coupled with an expanding understanding of endocrine pathophysiology, have elevated these tests from routine clinical tools to strategic instruments that drive patient-centric care. Increasing prevalence of conditions such as diabetes, thyroid dysfunction, and adrenal disorders has heightened the urgency for precise, reliable diagnostics. At the same time, personalized medicine initiatives are placing new demands on laboratories and test developers to deliver rapid, multiplexed, and minimally invasive solutions.

As regulatory agencies refine guidelines and reimbursement frameworks evolve, manufacturers and laboratories are compelled to reimagine their operational models. Investments in digital health platforms, artificial intelligence for data interpretation, and point-of-care testing are reshaping traditional workflows. This introduction establishes the foundational context for an in-depth exploration of how technological breakthroughs, tariff dynamics, segmentation strategies, regional variations, and competitive intelligence are collectively redefining the endocrine testing landscape.

Examining Transformative Shifts in Endocrine Diagnostics Fueled by Technological Breakthroughs, Regulatory Reforms, and Patient-Centric Care Models

In recent years, the endocrine diagnostics sector has undergone seismic shifts driven by cutting-edge technological innovation and changing regulatory expectations. The integration of tandem mass spectrometry and high-throughput immunoassays into core laboratory workflows has unlocked new levels of assay precision and throughput. Concurrently, regulatory agencies around the world have introduced more stringent validation requirements and quality benchmarks, prompting manufacturers to invest heavily in compliance and documentation processes.

Beyond the bench, patient empowerment and home-based testing models have emerged as transformative forces. Direct-to-consumer test offerings for hormone monitoring and telehealth platforms have blurred the boundaries between clinical settings and at-home care, fostering a more participatory approach to disease management. As laboratories and instrument providers adapt, strategic partnerships with digital health firms and data analytics companies are becoming increasingly commonplace. The confluence of these technological and patient-centric revolutions is redirecting capital flows, reshaping R&D priorities, and setting the stage for an era of highly personalized endocrine care.

Assessing the Cumulative Impact of United States Tariffs on Endocrine Testing Supply Chains and Market Operations throughout 2025 in a Dynamic Economy

The imposition of new tariff structures on imported reagents, instruments, and ancillary supplies in 2025 has cast a spotlight on the resilience of endocrine testing supply chains. Laboratories and instrument vendors have faced elevated input costs, prompting a comprehensive reassessment of procurement strategies. Many organizations are accelerating the diversification of their supplier networks and establishing regional distribution hubs to mitigate the risk of cost pass-through and shipment delays.

In response to these pressures, domestic manufacturers have seized the opportunity to expand production capacities, collaborating with local distributors to ensure continuity of service. End-users have initiated safety-stock buffering plans and negotiated long-term agreements to secure preferential pricing. Although upfront capital expenditures have risen, these strategic adjustments are laying the groundwork for more agile, de-risked operations. Ultimately, the tariff-driven recalibration of supply chains is fostering a renewed emphasis on localization, strategic inventory management, and operational flexibility.

Unveiling Critical Segmentation Insights That Demonstrate How Test Types, Product Categories, Sample Mediums, Technologies, Disease Classifications, and End Users Shape the Market

A deep dive into market segmentation reveals a complex tapestry of test types and applications that underpin the endocrine diagnostics ecosystem. Cortisol assays continue to serve as essential tools for evaluating adrenal function, while dehydroepiandrosterone sulfate testing has gained prominence in assessing adrenal androgen output. Estradiol measurement remains a cornerstone of reproductive health monitoring, and human chorionic gonadotropin testing supports both fertility management and pregnancy surveillance. Insulin assays are indispensable for glycemic control, sex hormone panels provide comprehensive endocrine profiling, and thyroid stimulating hormone analysis is foundational to thyroid disease management.

The instrumentation and consumable landscape is equally multifaceted. Chromatography systems, immunoassay analyzers, and mass spectrometry platforms represent the primary instrument categories driving laboratory modernization. Complementing these instruments, calibrators, control materials, and diagnostic kits enable rigorous quality assurance and assay standardization. Informatics solutions and maintenance services provide the digital infrastructure and technical support necessary to optimize uptime and data integrity.

Sample medium diversity further enriches testing approaches, encompassing blood draws, saliva collection, and urine samples to accommodate both conventional laboratory protocols and emerging at-home testing models. Underlying these modalities, a spectrum of technological platforms-including clinical chemistry, immunoassay, monoclonal and polyclonal antibody technologies, sensor innovations, and tandem mass spectrometry-delivers unparalleled sensitivity, specificity, and throughput.

Disease-centric segmentation highlights distinct demand drivers. The adrenal disorder segment, including Addison's disease and Cushing's syndrome, requires specialized assays for cortisol and adrenal androgens. Diabetes monitoring leverages insulin and related metabolic markers, whereas gonadal disorder evaluation, covering hypogonadism and polycystic ovary syndrome, relies on comprehensive sex hormone panels. Thyroid dysfunction analysis, spanning hyperthyroidism and hypothyroidism, centers on the precise quantification of thyroid stimulating hormone.

Finally, the end-user landscape spans academic institutions pursuing basic research, diagnostic laboratories implementing high-volume workflows, hospitals and clinics integrating point-of-care solutions, and research institutes driving translational discovery. Each segment presents unique operational requirements and strategic priorities, underscoring the importance of tailored solutions and collaboration across the value chain.

Highlighting Key Regional Dynamics across the Americas, Europe Middle East Africa, and Asia Pacific to Reveal Distinct Demand Patterns, Adoption Rates, and Growth Drivers

Regional dynamics within the endocrinology testing sphere exhibit pronounced diversity as operators navigate distinct regulatory landscapes, reimbursement frameworks, and patient demographics. In the Americas, well-established reimbursement pathways and mature laboratory networks facilitate rapid adoption of advanced assay platforms. Collaborative research initiatives between academic centers and commercial entities further bolster innovation pipelines and enable pilot deployments of novel diagnostic modalities.

The Europe, Middle East, and Africa region presents a heterogeneous tapestry of regulatory environments, from the European Union's harmonized directives to varied approval processes across Middle Eastern and African nations. This mosaic compels manufacturers to pursue adaptive market entry strategies, leveraging local partnerships and regulatory expertise. High population growth in certain markets augments demand for cost-effective, point-of-care solutions, while established institutions in Western Europe continue to demand high-precision laboratory instrumentation.

Across Asia-Pacific, rapid economic growth and expanding healthcare infrastructure are driving increased diagnostic investments. In countries with burgeoning middle-class populations, there is notable uptake of minimally invasive and at-home testing options. Governmental initiatives aimed at enhancing rural healthcare access are stimulating deployment of portable immunoassay systems and integrated telehealth platforms. Simultaneously, major regional manufacturers are investing in R&D to develop localized solutions that address endemic endocrine health challenges and align with national healthcare priorities.

Profiling Leading Industry Players to Showcase Strategic Collaborations, Innovation Portfolios, and Competitive Advances Shaping the Global Endocrine Testing Arena

Leading participants in the endocrine diagnostics arena are intensifying efforts to differentiate through strategic alliances, portfolio rationalization, and technological innovation. Established reagent and instrument providers are forging collaborations with biopharmaceutical companies to co-develop companion diagnostics, while diagnostics specialists are integrating digital health platforms to streamline data management and remote monitoring.

In the instrument segment, vendors are focusing on modular designs that accommodate both routine immunoassays and high-resolution mass spectrometry on a unified platform. Reagent manufacturers are prioritizing assay miniaturization and reagent stability to support at-home testing and decentralized laboratory models. Meanwhile, informatics providers are enhancing interoperability, embedding artificial intelligence algorithms for result interpretation, and enabling real-time connectivity across multi-site networks.

Emerging players are capitalizing on niche opportunities by developing sensor-based handheld devices and disposable immunoassay cards tailored for field use. Consolidation activities remain prevalent, as companies seek to expand their geographic footprints and accelerate time to market for innovative assays. This dynamic competitive choreography ensures that strategic investments in R&D, partnerships, and platform extensions will continue to delineate market leadership.

Delivering Actionable Recommendations for Industry Leaders Focused on Technology Integration, Strategic Partnerships, and Emerging Market Expansion in Endocrine Diagnostics

Industry leaders should accelerate integration of next-generation technologies by adopting flexible platforms capable of simultaneous immunoassay and mass spectrometry analyses. Such convergence will streamline workflows and lower total cost of ownership. Concurrently, forging strategic partnerships with contract manufacturers and regional distributors can mitigate supply chain vulnerabilities and support rapid market entry in high-growth territories.

Investing in advanced informatics and artificial intelligence capabilities will enhance diagnostic accuracy and speed decision-making. By deploying cloud-based analytics, organizations can enable remote monitoring, predictive maintenance, and performance benchmarking across multi-site operations. Expanding footprint in emerging markets through localized manufacturing partnerships and regulatory collaborations can unlock new revenue streams and bolster global resilience.

Finally, embracing patient-centric service models, such as direct-to-consumer testing and telehealth integration, will differentiate service offerings and foster deeper engagement. By aligning product roadmaps with evolving reimbursement guidelines and payer expectations, companies can ensure sustained market access and drive long-term adoption across diverse healthcare settings.

Detailing the Comprehensive Research Methodology Employing Primary Interviews, Secondary Analysis, and Data Triangulation to Ensure Rigorous Market Insights

This analysis draws upon a rigorous, mixed-methods research design to ensure comprehensive coverage and analytical precision. Primary insights were gathered through structured interviews with C-suite executives, clinical laboratory directors, key opinion leaders, and procurement specialists. These conversations illuminated current operational challenges, unmet needs, and strategic priorities across the value chain.

Secondary data was meticulously compiled from peer-reviewed journals, regulatory agency publications, patent databases, company annual reports, and trade documentation. Each data point underwent triangulation to validate accuracy and minimize bias. Quantitative information was cross-referenced with historical performance indicators and industry benchmarks, while qualitative findings were synthesized through thematic analysis to identify emergent patterns.

A multi-stage validation process, including peer review by domain experts and technical stakeholders, further enhanced the reliability of the conclusions. Through these integrated research methodologies, the report delivers actionable intelligence that is grounded in empirical evidence and reflective of real-world market dynamics.

Concluding Perspectives Emphasizing Strategic Imperatives, Future Outlook, and Integrative Innovations that Will Guide the Evolution of Endocrine Testing Worldwide

The endocrine testing market stands at an inflection point, where rapid technological advancements, shifting regulatory regimes, and evolving patient expectations converge to redefine diagnostic paradigms. Segmentation analysis underscores the diverse needs of clinical laboratories, research entities, and point-of-care providers, while regional insights highlight the importance of adaptive market entry strategies.

Competitive profiling reveals that success will hinge on the ability to integrate multidisciplinary capabilities-from assay innovation and digital health integration to strategic supply chain partnerships. Actionable recommendations emphasize the need for flexible platforms, robust informatics, and targeted expansion into underserved regions.

As industry stakeholders navigate these complexities, sustained collaboration and a relentless focus on quality, compliance, and patient outcomes will dictate long-term resilience. By leveraging the insights contained herein, decision makers can chart a clear path forward, positioning their organizations to capitalize on the next wave of innovation in endocrine diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endocrine Testing Market, by Type

  • 8.1. Cortisol Test
  • 8.2. Dehydroepiandrosterone Sulfate (DHEAS) Test
  • 8.3. Estradiol (E2) Test
  • 8.4. Human Chorionic Gonadotropin (hCG) Hormone Test
  • 8.5. Insulin Test
  • 8.6. Sex Hormone Tests
  • 8.7. Thyroid Stimulating Hormone (TSH) Test

9. Endocrine Testing Market, by Product Type

  • 9.1. Instruments
    • 9.1.1. Chromatography Systems
    • 9.1.2. Immunoassay Analyzers
    • 9.1.3. Mass Spectrometry Systems
  • 9.2. Reagents & Kits
    • 9.2.1. Calibrators
    • 9.2.2. Control Materials
    • 9.2.3. Diagnostic Kits
  • 9.3. Software And Services
    • 9.3.1. Informatics Solutions
    • 9.3.2. Maintenance Services

10. Endocrine Testing Market, by Sample Type

  • 10.1. Blood
  • 10.2. Saliva
  • 10.3. Urine

11. Endocrine Testing Market, by Technology

  • 11.1. Clinical Chemistry
  • 11.2. Immunoassay
  • 11.3. Monoclonal & Polyclonal Antibody Technologies
  • 11.4. Sensor Technology
  • 11.5. Tandem Mass Spectrometry

12. Endocrine Testing Market, by Disease Type

  • 12.1. Adrenal Disorders
    • 12.1.1. Addison's Disease
    • 12.1.2. Cushing's Syndrome
  • 12.2. Diabetes
  • 12.3. Gonadal Disorders
    • 12.3.1. Hypogonadism
    • 12.3.2. Polycystic Ovary Syndrome
  • 12.4. Thyroid Dysfunction
    • 12.4.1. Hyperthyroidism
    • 12.4.2. Hypothyroidism

13. Endocrine Testing Market, by End User

  • 13.1. Academic Institutions
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals & Clinics
  • 13.4. Research Institutes

14. Endocrine Testing Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Endocrine Testing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Endocrine Testing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Endocrine Testing Market

18. China Endocrine Testing Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. ACON Laboratories, Inc.
  • 19.7. Agilent Technologies, Inc.
  • 19.8. Bio-Rad Laboratories Inc
  • 19.9. BioCheck Inc.
  • 19.10. Biogenix Inc. Pvt. Ltd
  • 19.11. bioMerieux SA
  • 19.12. Blueprint Genetics Oy
  • 19.13. Creative Diagnostics
  • 19.14. Danaher Corporation
  • 19.15. Diagnostic Automation/Cortez Diagnostics Inc.
  • 19.16. DiaSorin S.p.A.
  • 19.17. Eagle Biosciences
  • 19.18. EKF Diagnostics Holdings Plc
  • 19.19. Eli Science Inc.
  • 19.20. Eurofins Analytical Laboratories Inc.
  • 19.21. F. Hoffmann-La Roche Ltd
  • 19.22. Getein Biotech, Inc.
  • 19.23. Laboratory Corporation of America Holdings
  • 19.24. MP Biomedicals, LLC
  • 19.25. Ortho-Clinical Diagnostics, Inc.
  • 19.26. Quest Diagnostics Incorporated
  • 19.27. Randox Laboratories Ltd.
  • 19.28. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • 19.29. Siemens Healthcare GmbH
  • 19.30. Thermo Fisher Scientific Inc.
  • 19.31. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. G7 ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. G7 ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 298. G7 ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. NATO ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 306. NATO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. NATO ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. NATO ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 310. NATO ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. NATO ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA ENDOCRINE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2